Nirman Agri Genetics Limited, headquartered at 3rd floor, Samarth House, Opposite Titan World, Mahatma Nagar, Nashik, has announced key decisions taken at its Board Meeting held on 6th October 2025. The meeting was a rescheduled session following the earlier postponed meeting notice dated 30th September 2025. The Board approved major corporate actions including sub-division of shares, bonus issue, and increase in authorized share capital.

The first major decision involves the sub-division or stock split of equity shares. Each existing equity share of Rs 10 will be split into 10 equity shares of Rs 1 each. The split is aimed at enhancing liquidity of the shares in the market and making them more accessible to retail investors. The record date for the stock split will be announced in due course. The pre and post share capital for authorized, issued, and paid-up shares has been defined, showing a tenfold increase in the number of shares while maintaining the overall capital value.

The Board also approved a bonus issue of equity shares in the ratio of 10 to 1, meaning shareholders will receive 10 bonus shares for every 1 existing share held as on the record date. The bonus shares will be issued by capitalizing the securities premium account and/or free reserves, subject to shareholder approval. The total number of bonus shares to be issued is 72,08,70,840, each with a face value of Rs 1. The estimated time for completion of the bonus issue is within two months from the date of Board approval. The figures used are audited and reflect reserves available as on 31st March 2025, including securities premium of Rs 65,17,13,804 and free reserves of Rs 36,81,04,099.

Another significant decision was to increase the authorized share capital of the company from Rs 15 crore to Rs 90 crore, following the bonus issue and stock split. Consequently, Clause 5 of the Memorandum of Association has been amended to reflect the new authorized capital of Rs 90,00,00,000 divided into 90,00,00,000 equity shares of Rs 1 each. This amendment ensures compliance with statutory requirements and aligns the memorandum with the corporate actions approved by the Board.

The Board also approved the draft Postal Ballot Notice to seek shareholder approval for the sub-division, bonus issue, and increase in authorized capital. M/s Vishakha Agrawal & Associates, Practicing Company Secretaries, Indore, have been appointed as the scrutinizer for the Postal Ballot process. The detailed disclosures for these actions are provided under Annexure A, Annexure B, and Annexure C as required under Regulation 30 of the SEBI Listing Regulations and SEBI circulars.

Annexure A outlines the sub-division of shares. One equity share of Rs 10 will be subdivided into 10 equity shares of Rs 1 each. The pre and post share capital for authorized, issued, and paid-up shares has been detailed. The expected completion time is approximately two months, pending shareholder and regulatory approvals. This sub-division applies to all equity shares, and no shareholders are excluded from the split.

Annexure B contains details of the bonus issue. The bonus shares will be issued from securities premium and free reserves. The bonus ratio is 10 to 1, resulting in the issuance of 72,08,70,840 new shares of Rs 1 each. Pre and post-bonus issue share capital shows an increase from Rs 15 crore authorized capital and Rs 8,00,96,760 paid-up shares to Rs 90 crore authorized capital and Rs 80,09,67,600 paid-up shares. The bonus shares are expected to be credited or dispatched within two months from Board approval.

Annexure C provides information on the increase in authorized share capital and amendment of Clause 5 of the Memorandum of Association. The authorized capital increases from Rs 15 crore divided into 1,50,00,000 equity shares of Rs 10 each to Rs 90 crore divided into 90,00,00,000 equity shares of Rs 1 each. The amendment ensures the Memorandum reflects the company’s expanded capital base.

The Board meeting commenced at 10:00 AM and concluded at 12:30 PM. These decisions demonstrate the company's proactive approach in improving share liquidity, rewarding shareholders, and aligning the capital structure with future growth. The corporate actions, once completed, are expected to enhance investor confidence and market participation in Nirman Agri Genetics Limited.

Overall, these measures reflect strong corporate governance practices, compliance with SEBI regulations, and commitment to shareholder value creation. Nirman Agri Genetics Limited continues to focus on strategic initiatives that strengthen its equity base, improve liquidity, and provide tangible benefits to existing and potential investors.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.